About Biokart
Biokart is a company based in Bengaluru (India) founded in 2011. It operates as a B2B. Biokart offers products and services including Sanger Based Services, NGS Based Services, and Bioinformatics Services. Biokart operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biokart India Private Limited
- Date of Incorporation 22 Dec, 2011
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$655.73 K (USD)209.41as on Mar 31, 2023
-
Net Profit
$18.9 K (USD)95.91as on Mar 31, 2023
-
EBITDA
$67.04 K (USD)268.53as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biokart
Biokart offers a comprehensive portfolio of products and services, including Sanger Based Services, NGS Based Services, and Bioinformatics Services.
Provides DNA sequencing for research and analysis purposes.
Offers high-throughput sequencing for microbial and genomic studies.
Delivers computational tools for genomics data interpretation and processing.
Funding Insights of Biokart
Detailed funding history for Biokart
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biokart
Investment portfolio details for Biokart
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biokart
Detailed financials for Biokart
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biokart Comparisons
Peer comparison for Biokart
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biokart
Biokart operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Beikang Medical and Macrogen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genome sequencing, analysis, and genetic screening services are provided.
|
Detailed competitors of Biokart
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biokart
Complete news archive for Biokart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biokart
Biokart was founded in 2011.
Biokart is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Annual revenue of Biokart is $655.73K as on Mar 31, 2023.
Biokart India is a leading genomics company that leverages advanced technologies for nucleic acid extraction, sequencing, and informatics analysis. They provide tailored services like Sanger and NGS-based solutions, supporting research in microbial genomics and beyond. Based primarily in Bengaluru, India, with branches in Lucknow and Delhi, they collaborate with institutions such as IGIMS for projects like COVID-19 genome sequencing. Their focus is on delivering high-quality, reliable results to clients in the biotechnology sector.
Biokart's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Biokart offers Sanger Based Services, NGS Based Services, and Bioinformatics Services.